IE40829B1 - Tertiary alcohol stabilized e-series prostaglandins - Google Patents

Tertiary alcohol stabilized e-series prostaglandins

Info

Publication number
IE40829B1
IE40829B1 IE564/75A IE56475A IE40829B1 IE 40829 B1 IE40829 B1 IE 40829B1 IE 564/75 A IE564/75 A IE 564/75A IE 56475 A IE56475 A IE 56475A IE 40829 B1 IE40829 B1 IE 40829B1
Authority
IE
Ireland
Prior art keywords
tertiary alcohol
series prostaglandins
alcohol stabilized
stabilized
series
Prior art date
Application number
IE564/75A
Other languages
English (en)
Other versions
IE40829L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE40829L publication Critical patent/IE40829L/xx
Publication of IE40829B1 publication Critical patent/IE40829B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE564/75A 1974-04-19 1975-03-14 Tertiary alcohol stabilized e-series prostaglandins IE40829B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (2)

Publication Number Publication Date
IE40829L IE40829L (en) 1975-10-19
IE40829B1 true IE40829B1 (en) 1979-08-29

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
IE564/75A IE40829B1 (en) 1974-04-19 1975-03-14 Tertiary alcohol stabilized e-series prostaglandins

Country Status (23)

Country Link
US (1) US3927197A (US08124317-20120228-C00060.png)
JP (1) JPS5337408B2 (US08124317-20120228-C00060.png)
AR (1) AR213271A1 (US08124317-20120228-C00060.png)
AT (1) AT348130B (US08124317-20120228-C00060.png)
AU (1) AU470631B2 (US08124317-20120228-C00060.png)
BE (1) BE828065A (US08124317-20120228-C00060.png)
BG (1) BG35326A3 (US08124317-20120228-C00060.png)
CA (1) CA1034044A (US08124317-20120228-C00060.png)
CS (1) CS191244B2 (US08124317-20120228-C00060.png)
DD (1) DD119131A5 (US08124317-20120228-C00060.png)
DE (1) DE2516105C3 (US08124317-20120228-C00060.png)
DK (1) DK138161B (US08124317-20120228-C00060.png)
ES (1) ES436613A1 (US08124317-20120228-C00060.png)
FI (1) FI62220C (US08124317-20120228-C00060.png)
FR (1) FR2267760B1 (US08124317-20120228-C00060.png)
GB (1) GB1474852A (US08124317-20120228-C00060.png)
HU (1) HU175405B (US08124317-20120228-C00060.png)
IE (1) IE40829B1 (US08124317-20120228-C00060.png)
IL (1) IL46994A (US08124317-20120228-C00060.png)
LU (1) LU72320A1 (US08124317-20120228-C00060.png)
NL (1) NL158384B (US08124317-20120228-C00060.png)
PH (1) PH11697A (US08124317-20120228-C00060.png)
SE (1) SE428528B (US08124317-20120228-C00060.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (US08124317-20120228-C00060.png) 1976-03-17
PH11697A (en) 1978-05-24
JPS5337408B2 (US08124317-20120228-C00060.png) 1978-10-09
CS191244B2 (en) 1979-06-29
ES436613A1 (es) 1977-04-16
FI751108A (US08124317-20120228-C00060.png) 1975-10-20
SE428528B (sv) 1983-07-11
DK138161B (da) 1978-07-24
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (US08124317-20120228-C00060.png) 1975-10-20
JPS50145515A (US08124317-20120228-C00060.png) 1975-11-21
AU470631B2 (en) 1976-03-25
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (US08124317-20120228-C00060.png) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (US08124317-20120228-C00060.png) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
DD119131A5 (US08124317-20120228-C00060.png) 1976-04-12
AU7987775A (en) 1976-03-25
DK138161C (US08124317-20120228-C00060.png) 1979-01-02

Similar Documents

Publication Publication Date Title
IE40829B1 (en) Tertiary alcohol stabilized e-series prostaglandins
AU6835374A (en) 5-oxa prostaglandin analogues
AU501389B2 (en) Prostaglandin analogues
AU502672B2 (en) Prostaglandin analogue alcohols
AU497401B2 (en) Prostaglandin compositions
AU502586B2 (en) Prostaglandin analogue alcohols
AU8587775A (en) Ester derivatives of prostaglandin e2 analogues
AU1868776A (en) Prostaglandin analogues and pharmaceutical compositions
HU173114B (hu) Novyj sposob poluchenija f vniz 2 al'fa prostaglandina i ego analogov
AU7153074A (en) Cycloalkylidenol & cycloalkenol analogues of prostaglandins e & f
AU509474B2 (en) Alcohol analogues of prostaglandins
NZ179192A (en) Prostaglandin analogues and pharmaceutical compositions
AU502124B2 (en) Analogues of prostanoic acids
AU506972B2 (en) Lactones of prostaglandins and prostaglandin analogue
AU493588B2 (en) Improvements relating tothe gasification of solid fuel
AU485720B2 (en) Phenacyl-type esters of pge, and its analogs z
AU495210B2 (en) 13, 14-dihydro prostaglandin analogues
AU8266675A (en) Improvements relating tothe gasification of solid fuel
AU8330775A (en) Phenacyl-type esters of pge, and its analogs z
AU473986B2 (en) Fluorinated prostaglandin analogues
AU480745B2 (en) Improvements relating to lighters
AU489270B1 (en) Improvements relating to press brakes
AU1260376A (en) 13, 14-dihydro prostaglandin analogues
CA991867A (en) Movable wall for engine nozzle
AU465845B2 (en) Phosphatide derivatives of prostaglandins